SUMMIT THERAPEUTICS INC
SMMT · NASDAQ
Updated at 2026-10-14 10:59:02
- Today's High
- $16.79
- Today’s Low
- $15.46
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $17.47
- Previous Close
- $17.13
- Volume
- 4.37M
- Market Cap
- $13.69B
- P/E Ratio
- --
- EPS
- $-1.11
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 601 BRICKELL KEY DRIVE, MIAMI, FL, UNITED STATES, 33131
- Country
- US
- Listing Date
- 2004-10-14
- Fiscal Year End
- December
- Shares Outstanding
- 797.75M
- CIK
- 0001599298
- Website
- www.smmttx.com
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America, and Europe. The company is headquartered in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$220.49M
2026-03-31
$195.21M
2025-12-31
$224.87M
2025-09-30
$234.21M
Net Income
2026-06-30
-$215.7M
2026-03-31
-$189.42M
2025-12-31
-$219.17M
2025-09-30
-$231.79M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.28
2026-03-31
$-0.17
2025-12-31
$-0.21
2025-09-30
$-0.23
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$215.65M
2026-03-31
-$189.38M
2025-12-31
-$219.08M
2025-09-30
-$231.75M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $220.49M | $195.21M | $224.87M | $234.21M |
| Net Income | -$215.7M | -$189.42M | -$219.17M | -$231.79M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.28 | $-0.17 | $-0.21 | $-0.23 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$215.65M | -$189.38M | -$219.08M | -$231.75M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.